Jordan H. Smiley


Jordan Smiley is a member of the Health Care Practice Group within Foley & Lardner LLP’s Business Law Department. She is based in the Los Angeles office.

Jordan’s knowledge covers a wide range of regulatory guidance within the health care sector. She has a thorough understanding of reproductive health care regulations, ensuring compliance with laws governing the evolving legal landscape. Additionally, Jordan is well-versed in telehealth regulations, an assists start-up companies in developing policies and procedures that adhere to complex health care requirements. Furthermore, Jordan is skilled in addressing consent laws, ensuring providers are protected and patient safety is prioritized from the onset of a patient-provider relationship. Jordan is also adept at addressing disciplinary actions in response to medical board inquiries and staying abreast of state-sponsored initiatives and waiver programs. In terms of transactional work, Jordan has experience in health care mergers and acquisitions and drafting meticulous employment agreements tailored to the unique needs of health care professionals.

Jordan began her career at Foley & Lardner LLP as a summer associate in 2022. Prior to joining Foley, Jordan worked as a case manager at a litigation firm where she oversaw third-party communications, evidence collection, and preparation of court filings. Jordan also worked at Disability Rights California where she served as an advocate for clients seeking at-home healthcare via Medicaid.

Community Involvement

  • Volunteer, Foxy and the Hounds, a local Southern California non-profit that serves to rehabilitate injured, neglected, and abused dogs at risk of euthanasia

Presentations and Publications

01 April 2024 Health Care Law Today

FDA: New Guidance for Non-interventional Studies of Drug Safety and Effectiveness

The FDA has recently issued guidance for sponsors and investigators interested in submitting a non-interventional study, commonly known as an observational study, to contribute evidence of a drug’s safety and effectiveness.
27 March 2024 Health Care Law Today

Health-Related Social Needs: Three Trends in Leveraging Community Partnerships

Three trends in community partnerships to address the struggle with interventions to impact individuals’ health-related social needs (HRSN).
22 March 2024 In the News

Foley LA Prepares Boys & Girls Clubs Students for Youth of the Year Competition

Foley & Lardner LLP partner Nicholas Gross and associates Trevor Mullin, Kathryn Petrosky, Jordan Smiley, Savannah Levin, Troy Tessem, and Tam Wheat helped prepare students from the Boys & Girls Clubs of Metro Los Angeles for the annual Youth of the Year competition.
14 March 2024 Health Care Law Today

Clinical Research: FDA Issues Draft Guidance on Informed Consent

The U.S. Food and Drug Administration, in collaboration other agencies, recently published draft guidance on effectively presenting key information regarding informed consent in FDA-regulated clinical investigations of medical products and Department of Health and Human Services supported human subjects research.
16 January 2024 Press Releases

Foley’s Los Angeles Office Hosts Street Law Program in Partnership with Boys & Girls Clubs

Foley & Lardner LLP’s Los Angeles office recently partnered with the Boys & Girls Clubs of Metro Los Angeles in South Central and the Los Angeles Boys & Girls Club in Lincoln Heights for a second Street Law program.
06 December 2023 Health Care Law Today

FDA’s Final Rule on Direct-to-Consumer Advertising – Presentation of Risk Information

In November 2023, the FDA published its final rule to amend its regulations concerning radio and television DTC advertisements for human prescription drugs by firms, which includes manufacturers, packers, and distributors of prescription drugs and all of their representatives, including both individuals and corporate entities.